Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →
Investors from TEDCO and Blackbird Labs told Baltimore founders what really gets a deal moving. The short version: show your work, and keep showing it. I moderated the “What Investors Want” panel at the Fueling your Technology event hosted by ETC Baltimore. It was a very relevant discussion to lead since I am raising capital […]
Read More →North Carolina – Regional Life Sciences Roundup -October 16th, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection […]
Labcorp (NYSE: LH), the Burlington, North Carolina-based laboratory services company, and OPKO Health (Nasdaq: OPK) announced on October 15, 2026 an agreement for Labcorp to acquire select assets of BioReference Health, LLC, a wholly owned subsidiary of OPKO. Labcorp will pay $722 million in cash at closing, subject to adjustment based on closing business revenues, […]
Opus Genetics , a Research Triangle Park, North Carolina-based clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases (IRDs), presented clinical findings from its OPGx-BEST1 and OPGx-LCA5 programs at Retina in Rio 2026 in Rio de Janeiro, Brazil, the company announced on October 15, 2026. “The data presented at Retina in Rio highlight meaningful […]
IQVIA and Veeva Systems announced on October 13, 2026 an expansion of their partnership. IQVIA has selected Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications to be used across its clinical development studies. The move extends the companies’ previously announced electronic data capture (EDC) partnership. “By bringing our companies’ strengths together, […]
Alamance Community College (ACC) in Graham, North Carolina, has received $474,878 from the National Science Foundation’s Advanced Technological Education (NSF-ATE) program to launch BioQuest, an initiative preparing students for careers in biopharma quality, the college announced on October 7, 2026. ACC is one of only two North Carolina institutions to receive NSF-ATE funding focused on […]
Liquidia Corporation, a Morrisville, North Carolina-based biopharmaceutical company, announced on October 13, 2026 a global settlement agreement with United Therapeutics Corporation that resolves all six pending lawsuits between the companies. Under the settlement, YUTREPIA® (treprostinil) inhalation powder will remain available to patients with pulmonary arterial hypertension (PAH) without disruption. “We are always guided by our […]
BioHealth Capital Region – Regional Life Sciences Roundup – October 16, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a […]
Northwest Biotherapeutics, a Bethesda, Maryland-based biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced on October 8, 2026 a collaboration with the UK’s National Health Service Blood and Transplant (NHSBT) to support production of its experimental cancer vaccine DCVax®-L. NWBio says the agreement is the culmination of months of joint work between […]
Visara, Inc., a Rockville, Maryland-based ophthalmology company and majority-owned subsidiary of NovaBridge Biosciences (Nasdaq: NBP), announced on October 13, 2026 an exclusive license agreement with Wuhan Hiteck Biological Pharma Co., Ltd. for VIS-102 (HT006.2.2). VIS-102 is an investigational, next-generation modified recombinant human nerve growth factor (rhNGF) therapy designed to restore corneal health in patients with […]
